Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

AM-425 available for licensing

Oct. 25, 1996

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

NIH seeks licensees for antigenic MMP peptides with potential as therapeutic and diagnostic agents

Oct. 25, 1996

MMP/TNF production inhibitors reported by Pfizer

Oct. 25, 1996

Dimethaid seeks approval for treatment for arthritic pain

Oct. 18, 1996

Washington University's MCP regulates complement activity

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

University of North Carolina/Macronex research cytokine inhibitors

Oct. 18, 1996

Important milestone for Connective Therapeutics' ConXn

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...